NPI: 1750994828 · COSHOCTON, OH 43812 · Federally Qualified Health Center (FQHC) · NPI assigned 08/28/2020
Authorized official ATKINSON, DANIEL controls 20+ related entities in our dataset. Read more
| Authorized Official | ATKINSON, DANIEL (CEO) |
| NPI Enumeration Date | 08/28/2020 |
Other providers sharing the same authorized official: ATKINSON, DANIEL
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 2,491 | $31K |
| 2021 | 22,736 | $312K |
| 2022 | 33,191 | $477K |
| 2023 | 31,177 | $545K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T1015 | Clinic visit/encounter, all-inclusive | 12,606 | 11,063 | $909K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18,880 | 9,354 | $347K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3,078 | 1,681 | $37K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,936 | 1,043 | $30K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2,192 | 1,126 | $12K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 527 | 291 | $9K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 371 | 184 | $9K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 927 | 386 | $5K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 57 | 33 | $2K |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 76 | 62 | $2K |
| 87428 | 61 | 39 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 118 | 68 | $791.19 |
| 81003 | 205 | 112 | $163.89 | |
| 71046 | Radiologic examination, chest; 2 views | 22 | 12 | $161.92 |
| Q3014 | Telehealth originating site facility fee | 116 | 71 | $148.96 |
| 99441 | 25 | 14 | $127.12 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 21 | 13 | $13.94 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 21 | 12 | $8.16 |
| G8482 | Influenza immunization administered or previously received | 351 | 171 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 8,757 | 4,538 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 6,487 | 3,349 | $0.00 |
| G8484 | Influenza immunization was not administered, reason not given | 9,363 | 4,710 | $0.00 |
| 4004F | 4,464 | 2,290 | $0.00 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 70 | 36 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 160 | 76 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 4,365 | 2,237 | $0.00 |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 3,940 | 2,014 | $0.00 |
| 1036F | 4,184 | 2,182 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 4,181 | 2,181 | $0.00 |
| 3017F | 577 | 307 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 1,151 | 592 | $0.00 |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 100 | 57 | $0.00 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 55 | 26 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 130 | 74 | $0.00 |
| G9908 | Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 21 | 12 | $0.00 |